Publikationen in Zusammenarbeit mit Forschern von Institute of Clinical and Experimental Medicine (1)

2022

  1. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

    Journal of Clinical Endocrinology and Metabolism, Vol. 107, Núm. 9, pp. 2644-2651